Advertisement

Tenet Healthcare Corporation THC

Set alert

Price alert · THC

All alert types
273.25 USD +2.68 +0.99%

At close · Oct 30

273.25 0.00 0.00%

After hours · Oct 30, 4:34 PM ET

Bid
273.00 × 100
Ask
273.37 × 100
265.58 Day range 274.09
161.37 52-week range 280.77
YTD
+37.51%
1 year
+30.98%
Open
266.51
Prev close
270.57
Mkt cap
22.00B
Vol
1.21M
Avg vol
748.23K
EPS
25.88
P/E
10.56
Div yield
0.00%
More statistics
Low
265.58
High
274.09
Forward P/E
12.84
Beta
1.20
Short ratio
2.63
Inst. own
101.92%
Dividend
0.00
Ex-div date
Mar 12, 2000
Earnings
Feb 10, 2027
50-d avg
264.86
200-d avg
219.82
1y target
286.41

6M chart

Chart tools
Interval

Events in this range
  • Jul 22, 2026Earnings: 6.12; estimate 4.26; surprise 43.66%
  • Jul 28, 2026Rating: Truist Securities · Buy → Buy
  • Aug 3, 2026Rating: Wells Fargo · Overweight → Overweight
  • Sep 18, 2026Rating: Leerink Partners · Outperform → Outperform
  • Sep 23, 2026Rating: BMO Capital · — → Market Perform
  • Oct 16, 2026Rating: Guggenheim · Buy → Buy
  • Oct 29, 2026Earnings: 6.64; estimate 4.68; surprise 41.88%
  • Oct 30, 2026Rating: Guggenheim · Buy → Buy
Signals (30)
NameDateAgo
MACD: Buy SignalOct 30, 20261 day ago
SMA: BullishOct 28, 20263 days ago
SMA: BearishOct 27, 20264 days ago
MACD: Sell SignalOct 27, 20264 days ago
SMA: BullishOct 9, 20263 weeks ago
MACD: Buy SignalOct 9, 20263 weeks ago
SMA: BearishSep 29, 20261 month ago
SMA: BullishSep 25, 20261 month ago
SMA: BearishSep 24, 20261 month ago
RSI: OverboughtAug 20, 20262 months ago
RSI: OverboughtAug 18, 20262 months ago
MACD: Sell SignalAug 17, 20262 months ago
RSI: OverboughtAug 12, 20262 months ago
RSI: OverboughtAug 7, 20262 months ago
RSI: OverboughtAug 4, 20262 months ago
MACD: Buy SignalJul 24, 20263 months ago
RSI: OverboughtJul 24, 20263 months ago
SMA: BullishJul 21, 20263 months ago
SMA: BearishJul 17, 20263 months ago
SMA: BullishJul 16, 20263 months ago
SMA: BullishJul 15, 20263 months ago
SMA: BearishJul 14, 20263 months ago
MACD: Sell SignalJul 14, 20263 months ago
SMA: BearishJul 13, 20263 months ago
SMA: BullishJul 2, 20264 months ago
RSI: OverboughtJul 2, 20264 months ago
SMA: BullishJun 24, 20264 months ago
MACD: Buy SignalJun 11, 20264 months ago
MACD: Sell SignalMay 21, 20265 months ago
MACD: Buy SignalMay 4, 20266 months ago

Key statistics

Market cap
21.80B
Enterprise value
36.40B
Trailing P/E
10.46
Forward P/E
12.84
PEG ratio
1.88
Price / sales
0.98
Price / book
4.68
EPS (TTM)
25.88
Beta
1.20
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
13.09%
Revenue (TTM)
22.15B
Revenue growth
6.50%
Free cash flow
2.00B
Total cash
2.67B
Total debt
13.24B
Return on equity
41.70%
Shares outstanding
80.52M
Short % of float
2.68%
50-day average
264.86
200-day average
219.82

Analyst view

Consensus: buy

Buy
Price target (mean) 286.41 +4.8% upside
Target (low)
260.00
Target (mean)
286.41
Target (high)
315.00
Ratings (0m) 23 19 buy · 4 hold · 0 sell
  • Strong buy5
  • Buy14
  • Hold4
  • Sell0
  • Strong sell0

Next earnings

Feb 10, 2027

Expected Feb 10, 2027. Consensus EPS estimate 5.67.

Earnings history

Financials — quick view

All financials
THC Revenue — quarterly 6.28B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
THC Net income — quarterly 1.00B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
THC EPS — quarterly 12.48
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

THC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 10, 2027Dec 30, 20265.45———
Oct 29, 2026Sep 30, 20264.686.64+1.96+41.88%
Jul 22, 2026Jun 30, 20264.266.12+1.86+43.66%
Apr 30, 2026Mar 31, 20264.174.82+0.65+15.59%
Feb 11, 2026Dec 31, 20254.074.70+0.63+15.48%
Oct 28, 2025Sep 30, 20253.343.70+0.36+10.78%

Upgrades / downgrades

THC analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026GuggenheimmainBuyBuy
Oct 16, 2026GuggenheimmainBuyBuy
Sep 23, 2026BMO Capitalinit—Market Perform
Sep 18, 2026Leerink PartnersmainOutperformOutperform
Aug 3, 2026Wells FargomainOverweightOverweight
Jul 28, 2026Truist SecuritiesmainBuyBuy

About Tenet Healthcare Corporation

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

Sector
Healthcare
Industry
Medical Care Facilities
Country
United States

News

Your note

Sign in to keep a note on THC — it syncs with the Stock Master app.

Insider holders

THC insider holders
InsiderRelationLatest transactionDateShares held
ARBOUR PAOLA MChief Technology OfficerSaleJul 26, 202618,413
BIERMAN JAMES LDirectorSaleJul 26, 202631,604
FISHER RICHARD W.DirectorConversion of Exercise of derivative securityMay 21, 20269,632
FITZGERALD MEGHANDirectorConversion of Exercise of derivative securityMay 21, 202617,087
HANEY CECIL D.DirectorStock GiftAug 27, 202612,403
MARK RICHARD JDirectorSaleSep 9, 202625,121

Institution ownership

THC institution ownership
Holder% heldSharesValueReported
Blackrock Inc.10.86%8,743,0052.37BJun 29, 2026
Price (T.Rowe) Associates Inc9.88%7,957,4492.15BJun 29, 2026
Boston Partners5.51%4,433,3601.20BJun 29, 2026
Vanguard Portfolio Management LLC5.26%4,238,1081.15BJun 29, 2026
FMR, LLC4.96%3,994,5451.08BJun 29, 2026
Vanguard Capital Management LLC4.84%3,894,1891.05BJun 29, 2026

Fund ownership

THC fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Mid-Cap ETF3.56%2,868,116776.69MSep 29, 2026
TR PRICE-Price (T.Rowe) U.S. Value Equity Trust3.53%2,840,356769.17MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.40%2,734,962740.63MJun 29, 2026
T. Rowe Price Value Fund, Inc.2.60%2,092,106566.54MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.45%1,975,296534.91MJun 29, 2026
John Hancock Funds III-Disciplined Value Mid Cap Fund1.84%1,483,123401.63MAug 30, 2026
Advertisement